Recently, non-invasive imaging strategies using PET with radiolabeled FAP ligands have become available to characterize FAP expression in cardiovascular disease including acute ST-elevation myocardial infarction (STEMI) and severe aortic stenosis [12–14]. The gene discussed is FAP; the disease is cardiovascular disorder.